September 09 - 15:09
CRISPR tech platform Mammoth reaches unicorn status
CRISPR-based biotech startup Mammoth Biosciences has raised $150m in funding, reaching the status of tech unicorn. The Series D funding round was led by Redmile Group. Jennifer Doudna, one of Mammoth's founders is also one of the original discoverers of CRISPR and the recipient of the 2020 Nobel Prize in Chemistry. CRISPR is a technology that allows for the manipulation of genes.
> Tweets